Guardian Pharmacy Services, Inc. GRDN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.59% | 64.51% | -36.46% | 113.11% | 8.73% |
| Total Depreciation and Amortization | 2.13% | -2.81% | 4.09% | -1.66% | 6.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.89% | 64.27% | -46.18% | -7.34% | 6.53% |
| Change in Net Operating Assets | 644.26% | 83.22% | -844.72% | -65.31% | 1,658.27% |
| Cash from Operations | 44.45% | 395.30% | -82.48% | 22.83% | 41.30% |
| Capital Expenditure | 12.82% | 7.99% | -18.74% | 18.82% | -20.92% |
| Sale of Property, Plant, and Equipment | -- | -200.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 87.63% | 55.15% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -71.60% | -- | -- | -95.04% | 9.01% |
| Cash from Investing | -153.20% | 9.35% | -0.85% | 47.47% | 31.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.83% | 6.98% | -2.48% | 32.47% | -41.08% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -767.09% | 125.41% | -377.41% | 309.88% | 108.35% |
| Cash from Financing | -225.34% | 60.50% | -168.87% | 50.55% | 27.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.80% | 3,531.68% | -102.49% | 64.87% | 266.75% |